Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Plasma-based Multiomics Assay and Risk Scoring Model for Screening of Gastric Malignancies

NCT04947995 is registered in ClinicalTrials.gov with GeneCast Biotechnology Co., Ltd. as lead sponsor.

NCT NCT04947995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04947995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Plasma-based Multiomics Assay and Risk Scoring Model for Screening of Gastric Malignancies
Lead sponsor
GeneCast Biotechnology Co., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
June 15, 2021
Completion date
June 15, 2023
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer